First-line treatment with targeted therapies plus chemotherapy offered overall response benefits in BRAF V600E-mutant ...
LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun ...
Berenberg Bank analyst Kerry Holford maintained a Buy rating on Barry Callebaut AG (BARN – Research Report) on January 24 and set a price ...
GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.
GSK’s Shingrix new prefilled syringe presentation accepted for review by European Medicines Agency
GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...
A new cancer vaccine is being developed which scientists hope could target the disease before it takes hold. The University ...
This European review of the prefilled syringe follows GSK's receipt of approval from the US Food & Drug Administration on January 8. GSK is also investigating submission of the new presentation to ...
(Alliance News) - Pharmaceutical firm GSK PLC and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback